Laura Yecies is the CEO of Osteoboost Health, the company behind the first and only FDA-cleared, non-drug wearable for low bone density. Under her leadership, Osteoboost secured $4.7 million in NIH grants, raised $11 million in private capital, and generated $1 million in pre-orders within weeks of announcing the waitlist. She previously led Catch, a productivity app company sold to Apple, and Neurosync, a neurotechnology company. Earlier, she was CEO of SugarSync, which she scaled to $20 million in revenue and sold to J2 Global. She holds degrees from Harvard, Georgetown, and Dartmouth.
Why has there been so little progress against the rate of osteoporotic fractures and the associated morbidity and mortality? The deaths are real, the pain and suffering are real — and almost all of us have witnessed it. And, of course, the cost to our health system, $57 billion per year, is real.